you are here: HomeNewsBse
bse
Jump to
11605 Results Found
  • Seven of top 10 cos suffer combined loss of Rs 1.89 lakh cr in m-cap Feb 02, 2020 11:07 AM IST

    Seven of top 10 cos suffer combined loss of Rs 1.89 lakh cr in m-cap

    The 30-share BSE Sensex plummeted by 1,877.66 points to close below the key 40,000-mark at 39,735.53 last week.

  • D-Street Buzz: FMCG stocks jump ahead of Union Budget; HUL, ITC, Emami among top support Feb 01, 2020 11:06 AM IST

    D-Street Buzz: FMCG stocks jump ahead of Union Budget; HUL, ITC, Emami among top support

    In terms of index contribution, HUL, ITC, Godrej Corp, Emami, Colgate and GlaxoSmithKline Consumer Healthcare were at the top.

  • Power Grid share price cracks 5% after Q3 earnings Feb 01, 2020 10:28 AM IST

    Power Grid share price cracks 5% after Q3 earnings

    The company's shares slipped even though the company's numbers were in line with expectations.

  • NSE to launch RFQ platform for debt securities on February 4; BSE on February 3 Jan 31, 2020 07:55 PM IST

    NSE to launch RFQ platform for debt securities on February 4; BSE on February 3

    As a part of continuous market development initiatives to improve liquidity in debt market, the NSE said it is introducing RFQ platform, an electronic platform where market participants can negotiate their deals in any of the eligible securities.

  • Jubilant FoodWorks share price climbs 2%, hit fresh 52-week high Jan 31, 2020 12:15 PM IST

    Jubilant FoodWorks share price climbs 2%, hit fresh 52-week high

    The stock got traction after the company's December quarter numbers showed decent growth despite the slowdown in the economy.

  • JK Lakshmi Cement shares fall 3%; Kotak Securities downgrades stock to 'reduce' Jan 31, 2020 11:58 AM IST

    JK Lakshmi Cement shares fall 3%; Kotak Securities downgrades stock to 'reduce'

    The stock continues to be under pressure as the company's December quarter earnings failed to impress the market.

  • Arvind SmartSpaces Q3 net up 91% at Rs 19cr Jan 30, 2020 02:21 PM IST

    Arvind SmartSpaces Q3 net up 91% at Rs 19cr

    Total income rose to Rs 94.54 crore in the third quarter of 2019-20 fiscal, from Rs 77.83 crore in the corresponding period of the previous financial year.

  • Strides Pharma Science Q3 net declines 69% to Rs 92cr Jan 30, 2020 12:52 PM IST

    Strides Pharma Science Q3 net declines 69% to Rs 92cr

    However, the consolidated income of the company increased to Rs 744.66 crore in the October-December period, as against Rs 579.54 crore a year ago.

  • USFDA cautions Aurobindo Pharma's oral solids formulation facility of regulatory action Jan 30, 2020 12:05 PM IST

    USFDA cautions Aurobindo Pharma's oral solids formulation facility of regulatory action

    The company stressed that it will work closely with the US Food and Drug Administration (USFDA) to comprehensively address the issues.

  • Cholamandalam Financial Holdings Q3 profit up 5% at Rs 430cr Jan 29, 2020 02:40 PM IST

    Cholamandalam Financial Holdings Q3 profit up 5% at Rs 430cr

    Total income of the company rose to Rs 3,395.34 crore, from Rs 2,954.13 crore in the same period a year ago, Cholamandalam Financial Holdings said in a statement.

  • BSE to shift 30 stocks to restricted trading group, NSE to move 13 scrips Jan 29, 2020 02:10 PM IST

    BSE to shift 30 stocks to restricted trading group, NSE to move 13 scrips

    BSE will shift as many as 30 stocks, including McDowell Holdings, Emami Realty, United Van Der Horst, Hindustan Everest Tools, Technofab Engineering and Lactose India, to the trade-for-trade segment represented by T or XT groups.

  • Wabco India Oct-Dec profit drops 35% to Rs 39cr Jan 28, 2020 12:24 PM IST

    Wabco India Oct-Dec profit drops 35% to Rs 39cr

    The company had posted net profit (after tax) of Rs 59.7 crore in the year-ago period, Wabco India said in a filing to BSE.

  • Alembic Pharma gets final USFDA nod for infection treatment drug Jan 28, 2020 10:33 AM IST

    Alembic Pharma gets final USFDA nod for infection treatment drug

    "Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Azithromycin Tablets USP, 600 mg," the drug firm said in a filing to BSE.

  • Cipla gets EIR from USFDA for Invagen manufacturing facility Jan 28, 2020 10:31 AM IST

    Cipla gets EIR from USFDA for Invagen manufacturing facility

    "Following the inspection by the United States Food and Drug Administration (USFDA) at the lnvagen (US) manufacturing facility from December 2, 2019 to December 6, 2019, the company has received the establishment inspection report (EIR), indicating closure of the inspection," Cipla said in a filing to BSE.

  • D-Street Buzz: Pharma bucks the trend, 6 stocks hit fresh 52-week highs Jan 27, 2020 04:12 PM IST

    D-Street Buzz: Pharma bucks the trend, 6 stocks hit fresh 52-week highs

    The BSE Healthcare index emerged as the lone sectoral index that ended positive with a gain of 1.43%

  • Vodafone Idea share price falls 5% after PIL challenges DoT move on AGR Jan 27, 2020 03:43 PM IST

    Vodafone Idea share price falls 5% after PIL challenges DoT move on AGR

    The plea was filed by the Consumer Rights Foundation, which says DoT’s latest directions amount to contempt of court.

  • Ruchi Soya resumes trading, share price locked in 5% upper circuit Jan 27, 2020 01:04 PM IST

    Ruchi Soya resumes trading, share price locked in 5% upper circuit

    Haridwar-based Patanjali group, which has acquired debt-ridden Ruchi Soya, is expecting Rs 25,000 crore turnover this fiscal.

  • Yes Bank share price continues to surge, rises 4.4% Jan 24, 2020 11:58 AM IST

    Yes Bank share price continues to surge, rises 4.4%

    The stock logged a gain of 6.5 percent on January 23 after SBI chairman said the private lender was too big to be allowed to fail.

  • Strides Pharma arm gets tentative USFDA nod for skin ointment Jan 24, 2020 11:40 AM IST

    Strides Pharma arm gets tentative USFDA nod for skin ointment

    In a regulatory filing, the company said "its step-down wholly owned subsidiary, Strides Pharma Global Pte Ltd, Singapore, has received tentative approval for triamcinolone acetonide ointment USP, 0.05 percent from the United States Food & Drug Administration (USFDA)".

  • Alembic Pharma gets final USFDA nod for hypertension drug Jan 24, 2020 11:04 AM IST

    Alembic Pharma gets final USFDA nod for hypertension drug

    "Alembic Pharmaceuticals Ltd (Alembic) today announced it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Bosentan tablets, 62.5 mg and 125 mg," the firm said in a BSE filing.

  • BSE to introduce futures contracts on aluminium, zinc from January 27 Jan 23, 2020 08:42 PM IST

    BSE to introduce futures contracts on aluminium, zinc from January 27

    The exchange will introduce futures contracts on aluminium and zinc in commodity derivatives segment with effect from January 27, 2020, it said in a circular.

  • Granules India hit fresh 52-week high; brokerages positive on growth prospects Jan 23, 2020 12:19 PM IST

    Granules India hit fresh 52-week high; brokerages positive on growth prospects

    Domestic brokerage firm Sharekhan by BNP Paribas has maintained a positive view on the stock with an upside potential of 12-15 percent.

  • Alembic Pharma gets final USFDA nod for Fenofibrate tablets Jan 23, 2020 12:07 PM IST

    Alembic Pharma gets final USFDA nod for Fenofibrate tablets

    "Alembic Pharmaceuticals Limited (Alembic)...has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Fenofibrate Tablets USP, 54 mg and 160 mg.

  • JSW Steel plans to raise up to Rs 1,000cr via NCDs Jan 23, 2020 11:55 AM IST

    JSW Steel plans to raise up to Rs 1,000cr via NCDs

    The proceeds will be used to meet long-term working capital requirements, refinance existing debt, general corporate purpose and ongoing capital expenditure, the Sajjan Jindal-led company said in a filing to BSE.

  • Equity market to remain open for trading on the Budget day, Feb 1 Jan 23, 2020 10:27 AM IST

    Equity market to remain open for trading on the Budget day, Feb 1

    This will be the second Budget that will be presented by FM Nirmala Sitharaman, and is expected to provide key measures to boost the economy amid a slowdown

Sections